Cargando…
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations
Half of all cancer patients receive radiotherapy, which makes a substantial contribution to their long‐term disease control/cure. There are significant inter‐patient differences in response, both in terms of efficacy and toxicity (frequently delayed onset) which are difficult to predict. With the in...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682944/ https://www.ncbi.nlm.nih.gov/pubmed/34658150 http://dx.doi.org/10.1002/cjp2.246 |